1. Kedar, A., Cohen, M.E., Freeman, A.I.: Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II). Treatment: A case report. Cancer Treat. Rep. 62, 819?821 (1978)
2. Ostrow, St., Hahn, D., Wiernik, P.H., Richards, R.D.: Ophthalmologic toxicity after cis-Dichlorodiammine platinum (II). Therapy. Cancer Treat. Rep. 62, 1591?1594 (1978)
3. Piel, I.J., Meyer, D., Perlia, Ch.P., Wolfe, V.I.: Effects of cis-Diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother. Rep. 58, 871?875 (1974)
4. Stadnicki, S.W., Fleischmann, R.W., Schaeppi, U., Merriam, P.: Cis-Dichlorodiammineplatinum (II) (NSC-119875): Hearing loss and other toxic effects in rhesus monkeys. Cancer Chemother. Rep. 59, 467?480 (1975)
5. Tackmann, W., Lehmann, H.J.: Refractory period in human sensory nerve fibres. Europ. Neurol. 12, 277?292 (1974)